(888) 31-NDASA info@NDASA.COM
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • Facebook
  • Twitter
  • Instagram
  • RSS
  • NDASA
  • NDASA University
  • Member Login
0 Items
NDASA
  • About
    • Welcome DATIA Members
    • Leadership
  • Training
    • NDASA University
      • My Courses
    • Webinars
      • Webinar Library
    • Accreditation
    • Mentorship
  • Get involved
    • Committees
    • International Partnership
    • Become a Trainer
    • State Affiliate Caucus
    • Our Federal PAC
    • Board of Directors
  • Join us
    • Member Benefits
    • Sponsorships & Advertising
    • Accreditation
    • Preferred Provider
  • News
    • Resources
  • Events
    • 2023 Conference & Trade Show
    • 2022 Conference Highlights
  • Shop
  • Support
    • Sponsorships & Advertising
  • Contact
Select Page
Clearing Up Clearinghouse Confusion

Clearing Up Clearinghouse Confusion

by NDASA | Sep 25, 2020 | Drug & Alcohol Testing, Feature, FMCSA

Nearly a year after the opening of the Federal Motor Carrier Safety Administration Drug & Alcohol Clearinghouse, NDASA members continue to report some confusion among their clients and business partners when it comes to the federally mandated national...
It Takes a Village: Getting back to work safely

It Takes a Village: Getting back to work safely

by NDASA | May 15, 2020 | Industry News, Uncategorized

Over the last months as most of us have been at home, the National Drug and Alcohol Screening Association (NDASA) has focused on what working in the ‘new normal’ will look like for our industry. We’ve written about it, spoken to the experts, hosted virtual...
Supporting Employee Wellness During the COVID-19 Pandemic and Beyond

Supporting Employee Wellness During the COVID-19 Pandemic and Beyond

by NDASA | May 12, 2020 | Substance Use

By Karen Pierce, Working Partners* The last two and a half months have been a giant roller coaster ride, and not a fun one.  Employers have had to reexamine everything about their business – how to comply with ever-changing government guidelines, how to keep...
The Business of Getting Back to Business: 6 Steps for Reopening During COVID-19

The Business of Getting Back to Business: 6 Steps for Reopening During COVID-19

by NDASA | May 3, 2020 | Feature, Industry News

As we get ready to go back to work, businesses are facing new challenges and realities that are complicated by uncertainties about the progression of COVID-19. We know that it’s not just a matter of returning to normal. Continued social distancing, stringent cleaning...
The New Normal: How to ensure compliance during COVID-19

The New Normal: How to ensure compliance during COVID-19

by NDASA | Apr 16, 2020 | DOT, Feature

In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
NDASA Guidance and U.S. DOT Response to COVID-19

NDASA Guidance and U.S. DOT Response to COVID-19

by NDASA | Mar 3, 2020 | DOT, Feature, NDASA Guidance

In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...

Search this site

Stay in touch

  • Follow
  • Follow
  • Follow
  • Follow

Give to NDASA

Invest in safe and drug-free communities and workplaces and support NDASA.
Give now

Latest News & Updates

  • May 26, 2023Association Merger Announcement
  • May 01, 2023BREAKING NEWS: U.S. DOT Makes Final Rule on Oral Fluid Testing Available to the Public
  • Apr 28, 2023Countdown to Conference
  • Apr 10, 2023NDASA Celebrates Five Years
  • Mar 14, 2023Stay Current: Three Major Reports Reveal Disturbing Trend in Workplace Drug Abuse

Topics We Track

  • Advocacy (3)
  • Business Development (2)
  • Committee Reports (1)
  • DOT (7)
  • Drug & Alcohol Testing (26)
  • Drug Legislation (8)
  • Feature (69)
  • FMCSA (4)
  • For Drug Testing Industry Professionals (14)
  • For Employers and Workplace Safety & Wellness Professionals (12)
  • Industry News (20)
  • Marijuana & CBD (14)
  • Member Benefits (3)
  • Membership (6)
  • NDASA Conference (11)
  • NDASA Guidance (4)
  • Opioids (2)
  • Resources (21)
  • Substance Use (1)
  • Substance Use/Addiction (6)
  • Training (2)
  • Uncategorized (8)
  • Workplace Safety (6)

  • Association Merger Announcement
  • BREAKING NEWS: U.S. DOT Makes Final Rule on Oral Fluid Testing Available to the Public
  • Countdown to Conference
  • NDASA Celebrates Five Years
  • Stay Current: Three Major Reports Reveal Disturbing Trend in Workplace Drug Abuse

Archives

  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020

Categories

  • Advocacy
  • Business Development
  • Committee Reports
  • DOT
  • Drug & Alcohol Testing
  • Drug Legislation
  • Feature
  • FMCSA
  • For Drug Testing Industry Professionals
  • For Employers and Workplace Safety & Wellness Professionals
  • Industry News
  • Marijuana & CBD
  • Member Benefits
  • Membership
  • NDASA Conference
  • NDASA Guidance
  • Opioids
  • Resources
  • Substance Use
  • Substance Use/Addiction
  • Training
  • Uncategorized
  • Workplace Safety

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Facebook
  • Twitter
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress